Avicanna Inc (TSX:AVCN, OTCQX:AVCNF) has unveiled the initial portfolio offering for the MyMedi.ca cannabis care platform ahead of its launch on August 1.
The company said the platform servicing Medical Cannabis by Shoppers patients will offer a diverse portfolio of products, including 35 brands and more than 200 stock-keeping units (SKUs) from Canadian licensed producers.
Brands that will be available to purchase include CB4, Organigram, Bhang, Peace Naturals, Big Bag O’ Buds, Indiva, RHO Phyto, True North, Spinach FEELZ, SOURZ by Spinach, Olli, and White Rabbit, with more to come.
“We are pleased by the level of commitment towards patients that we have seen and the concrete support of this distinct group of Canadian licensed producers that have worked towards the timely launch of the new cannabis care platform, MyMedi.ca,” Avicanna CEO Aras Azadian said in a statement.
“We look forward to continuing to work collaboratively towards the goals of establishing MyMedi.ca as a leading cannabis care platform and towards taking steps to enhance the patient journey.”
Avicanna is a commercial-stage international biopharmaceutical company focused on the advancement and commercialization of evidence-based cannabinoid-based products for the global medical and pharmaceutical market segments.
Contact the author at emily.jarvie@proactiveinvestors.com
Follow her on Twitter @emilyjjarvie